Immune response in biocompatibility

Biomaterials

Volumn 13, Issue 11, 1992, Pages 731-743

  Remes, A ^a   Williams, D F ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

biocompatibility; immune response; Review

Indexed keywords

BIOMATERIAL; COMPLEMENT;

BIOCOMPATIBILITY; CELLULAR IMMUNITY; COMPLEMENT ACTIVATION; FOREIGN BODY; IMMUNE RESPONSE; LEUKOCYTE ACTIVATION; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; REVIEW;

ANIMAL; ANTIBODY FORMATION; BIOCOMPATIBLE MATERIALS; CHEMOTAXIS; COMPLEMENT ACTIVATION; HUMAN; IMMUNITY, CELLULAR; MACROPHAGE ACTIVATION; NEUTROPHILS;

EID: 0026657012     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/0142-9612(92)90010-L     Document Type: Review

References (147)

1. The interaction in vitro of Mycoplasma pulmonis with mouse peritoneal macrophages and L-cells
2. Human heat labile opsonins: evidence for their mediation via the alternative pathway of complement activation
3. Role of cell surface receptors in the regulation of intra-cellular killing of bacteria by murine peritoneal exudate neutrophils
4. Random locomotion, chemotaxis and chemokinesis. A guide to terms defining cell locomotion
5. H-2 compatibility requirement for T-cell mediated lysis of target cells infected with lymphocytic choriomeningitis virus: different T-cell specificities are associated with structures coded for in H-2K or H-2D
6. Requirements for the processing of antigens by antigen-presenting cells. I. Functional comparison of B cell tumors and macrophages
7. A comparison of the stimulatory activities of lymphoid dendritic cells and macrophages in T proliferative responses to various antigens
8. Antigen presentation by normal B-cells, B cell tumors and macrophages: functional and biochemical comparison
9. Identification of a macrophage antigen processing event required for I-region-restricted antigen presentation to T lymphocytes
10. The release of antigen molecules from macrophages: characterization of the phenomena
11. Cell-cycle control in lymphocyte stimulation
12. Interleukin-1 stimulation of human B-lymphoblast differentiation
13. Haemodialysis leukopenia: pulmonary vascular leukostasis resulting from complement activation by dialyser membranes
14. Complement activation and neutropenia occurring during cardiopulmonary bypass
15. Incidence of metal sensitivity in patients with total joint replacements
16. Metal sensitivity as a cause of bone necrosis and loosening of the prosthesis in total joint replacement
17. Human monocyte/macrophage activation and interleukin 1 generation by biomedical polymers
18. Activation of complement C3 by different calcium phosphate powders
19. Activation of the respiratory burst enzyme in human polymorphonuclear leukocytes by chemoattractants and other soluble stimuli
20. The ability of chemotactic factors to induce lysosomal enzyme release. I. The characteristics of the release, the importance of surfaces and the relation of enzyme release to chemotactic responsiveness
21. The influence of contact guidance on chemotaxis of human neutrophil leukocytes
22. Effect of intravascular complement activation on granulocyte adhesiveness and distribution
23. Anomalous preferences of cultured macrophages for hydrophobic and roughened substrata
24. Human leukocyte migration inhibition in agarose, using four antigens — correlation with skin reactivity
25. A visual analysis of chemotactic and chemokinetic locomotion of human neutrophil leukocytes
26. Chemotaxis and the inhibition of chemotaxis of human neutrophils in response to metal ions
27. Polyvalent cations inhibit human neutrophil chemotaxis by interfering with the polymerization of actin
28. The action of cobalt, nickel and chromium in phagocytosis and bacterial killing by human polymorphonuclear leukocytes: its relevance to infection after total joint arthroplasty
29. The binding of metal salts and corrosion products to cells and proteins in vitro
30. 63Ni complexes in rabbit skin serum and urine after injection of 63NiC12
31. Scanning electron microscopy of the metal-tissue interface. II. Observations with lead, copper, nickel, aluminium and cobalt
32. Blood distribution of nickel, cobalt and chromium following intra-muscular injection into hamsters
33. Positive and negative chemotaxis as observed after the destruction of a cell by U.V. or laser microbeams
34. The chemotactic activity of natured and denatured serum albumin
35. Lysosomal factors in inflammation
36. A study of the effects of particulate metals of orthopaedic interest on murine macrophages in vitro
37. Localised tissue infection and the influence of foreign bodies
38. Growth inhibition of cultured fibroblasts by cobalt and nickel
39. The pH of inflammatory exudates
40. Orientation of PMN in a pH gradient: acid induced release of a chemotactic factor
41. Acidosis of synovial fluid correlates with synovial fluid leukocytosis
42. The deleterious effect of reduced pH and hypoxia on neutrophil migration in vitro
43. Biomaterial associated impairment of local neutrophil function
44. A functional differentiation of human neutrophil granules: generation of C5a by a specific (secondary) granule product and inactivation of C5a by azurophil (primary) granule products
45. Generation of C5-derived lysosomal enzyme-releasing activity (C5a) by lysates of leukocyte lysosomes
46. C5 chemotactic fragments produced by an enzyme in lysosomal granules of neutrophils
47. Arachidonic acid metabolism in leukocytes
48. A potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes
49. Leukocyte locomotion and chemotaxis. New methods for evaluation and demonstration of a cell derived chemotactic factor
50. Polymorphonuclear leukocyte motility in vitro. III. Possible release of a chemotactic substance after phagocytosis of urate crystals by polymorphonuclear leukocytes
51. Polymorphonuclear leukocyte motility in vitro. V. Release of chemotactic activity following phagocytosis of calcium pyrophosphate crystals, diamond dust and urate crystals
52. Complement and immunoglobulins stimulate Superoxide production by human leukocytes independently of phagocytosis
53. The ability of chemotactic factors to induce lysosomal enzyme release. II. The mechanisms of release
54. Lung injury secondary to chemotactic factor induced leukocyte activation
55. Secretion of lysosomal enzymes induced by immune complexes and complement
56. The selective release of lysosomal acid hydrolases from mouse peritoneal macrophages by stimuli of chronic inflammation
57. Regulation of lysosomal enzyme secretion: role in inflammation
58. Oxygen radicals mediate endothelial cell damage by complement stimulated granulocytes. An in vitro model of immune vascular damage
59. Active oxygen species and the functions of phagocytic leukocytes
60. In vitro suppression of serum-elastase-inhibitory capacity by reactive oxygen species generated by phagocytosing polymorphonuclear leukocytes
61. A biochemical study of hydroxyapatite crystal induced enzyme release from neutrophils
62. The response to the intramuscular implantation of pure metals
63. Enzyme histochemistry of the tissue response to pure metal implants
64. The biological response to titanium and titanium-aluminium-vanadium alloy particles. I. Tissue culture studies
65. An in vitro study of exocytosis of neutrophil granule enzymes in chronic granulomatous disease neutrophils
66. Suppressive action of cobalt on exocytosis and respiratory burst in neutrophils
67. Influence of cadmium on the phagocytic and microbicidal activity or murine peritoneal macrophages and polymorphonuclear neutrophils
68. Functional immobilization of peritoneal macrophages by zinc
69. Activation of the complement system
70. Receptors for complement components in inflammation
71. Induction of interleukin-1 secretion and enhancement of humoral immunity by binding of human C5a to macrophage surface C5a receptors
72. C3a (C3a des Arg) induces production and release of interleukin 1 by cultured human monocytes
73. The complement system of man
74. The complement system of man
75. The complement system of man
76. The complement system of man
77. Homozygous deficiency of C3 in a patient with repeated infections
78. Depletion of plasma complement in vivo by a protein of cobra venom: its effect on various immunological reactions
79. Non immune chemotaxis in vivo: inhibition by complement depletion with cobra venom factor
80. A comparative study of different β-whitlockite ceramics in rabbit cortical bone with regard to their biogradation behaviour
81. The biological performance of calcium ceramics in an infected implantation site. III. Biological performance of β-whitlockite in the noninfected and infected rat middle ear
82. The role of membrane receptors for C3b and C3d in phagocytosis
83. Complement activation mediates cellular adhesion to synthetic biomaterials
84. The immunological release of constituents from neutrophil leukocytes. I. The role of antibody and complement on nonphagocytosable particles
85. Bioreactions at the tissue/hydroxyapatite interface
86. Macropore tissue ingrowth: a quantitative and qualitative study on hydroxyapatite ceramics
87. Solubilization of hydroxyapatite crystals by murine bone cells, macrophages and fibroblasts
88. C3 receptor-mediated production and release of interleukin 1 (IL-1) by human monocytes
89. An interleukin 1-like factor stimulates bone resorption in vitro
90. Neutrophil recruitment in skin window chambers — activation by complement
91. Complement components in relation to macrophage function
92. Defective release of C5a related chemo-attractant activity from complement in Crohn's disease
93. Neutrophil leukocyte chemotaxis: a simplified assay for measuring polarizing responses to chemotactic factors
94. Characterization of murine monoclonal antibodies that recognize neutralizing epitopes on human C5a
95. Complement (C5a)-induced granulocyte aggregation in vitro
96. Granulocyte aggregometry: a sensitive technique for the detection of C5a and complement activation
97. Transformation of monocytes in tissue culture into macrophages epithelioid cell and multinucleate giant cells
98. The local tissue response to biomaterials
99. Interaction of leukocyte chemotactic factors with the cell surface. I. Chemotactic factor-induced changes in human granulocyte surface charge
100. Anaphylatoxin formation during hemodialysis: effect of different dialyser membranes
101. Biocompatibility of different hemodialysis membranes: activation of complement and leukopenia
102. Independent effects of IgG and complement upon human polymorphonuclear leukocyte function
103. Complement and cell interactions in inflammatory reactions
104. Complement activation in vitro induced by endotoxin and injured tissue
105. Possible implication of complement in acute gout
106. Evaluation of nonspecific (alternative pathway) opsonic activity by neutrophil chemiluminescence
107. Different roles of IgG and complement receptors in phagocytosis by polymorphonuclear leukocytes
108. The role of immunoglobulins in alternative complement activation by zymosan. I. Human IgG with specificity for zymosan enhances alternative pathway activation by zymosan
109. Role of binding through C3b and IgG in polymorphonuclear neutrophil function: studies with trypsin generated C3b
110. Toxicity of silica. II. Characteristics of protein films absorbed by quartz
111. The role of fibronectin in the bioreactivity of material surfaces
112. Tissue reaction in rabbit muscle exposed to metallic implants
113. Effect of surface texture on the soft tissue response to polymer implants
114. Binding of IgG by monosodium urate monohydrate is a function of the ionic charge of the protein
115. Binding of IgG and complement protein by monosodium urate and other crystals
116. Absorption of human serum albumin by asbestiform minerals and its application to the measurement of surface areas of dispersed samples of chryostile
117. Interaction of some serum proteins with hydroxyapatite and other materials
118. Biological activity of aggregated gamma-globulin. IV. Mechanism of complement fixation
119. Complement activation by polymer binding IgG
120. Specific antibodies enhance sephadex-induced activation of the alternative complement pathway in human serum
121. IgG on mouse erythrocytes augments activation of the human alternative complement pathway by enhancing deposition of C3b
122. Complement activation by synthetic vascular prosthesis
123. Immunoglobulin G independent activation of the classical complement pathway by monosodium urate crystals
124. Complement activation and induction of interleukin 1 production during hemodialysis
125. Biochemical and histological evaluation of the synovial-like tissue around failed (loose) total joint replacement prosthesis in human subjects and a canine model
126. Differential production of IL-1 on the surface of biomaterials
127. Induction of contact sensitivity to a broad variety of allergens with haptenized macrophages
128. Isolation and characterization of Ni-specific T cell clones from patients with Ni contact dermatitis
129. Lymphocyte transformation test in allergic contact nickel dermatitis
130. In vitro investigations of chromium and nickel hypersensitivity with culture of skin and peripheral lymphocytes
131. Differential effects of eight metal ions on lymphocyte differentiation antigens in vitro
132. The haemolytic action of particulate metals
133. Stimulation of murine lymphocyte response by cations
134. Granuloma and plasma cell formation induced by the subcutaneous implantation of beta-whitlockite particles
135. Macroporous calcium phosphate bioceramics in dog femora, a histological study of interface and biodegradation
136. The synovial response to intra-articular Co-Cr-Mo particles in guinea pigs